Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$502K Buy
16,747
+2,378
+17% +$75.5K ﹤0.01% 1257
2025
Q4
$420K Sell
14,369
-276
-2% -$7.31K ﹤0.01% 1249
2025
Q3
$383K Buy
+14,645
New +$363K ﹤0.01% 1302
2024
Q4
Sell
-75,815
Closed -$1.76M 1498
2024
Q3
$1.76M Buy
75,815
+13,450
+22% +$316K 0.04% 431
2024
Q2
$1.39M Buy
62,365
+11,325
+22% +$242K 0.04% 485
2024
Q1
$1.13M Buy
51,040
+8,745
+21% +$178K 0.02% 543
2023
Q4
$790K Buy
42,295
+5,925
+16% +$108K 0.02% 628
2023
Q3
$683K Buy
+36,370
New +$680K 0.02% 616

Other funds holding IX

Vident Advisory's IX Position: Q1 2026 in Review

Vident Advisory increased its ORIX (IX) stake by 17% in Q1 2026, buying an estimated $75.5K and bringing the position to 16,747 shares worth $502K. The position accounts for ﹤0.01% of the portfolio, ranked #1257.

Vident Advisory first reported a position in IX in Q3 2023 and has held it in 8 quarters since. The position peaked at $1.76M in Q3 2024. 280 funds tracked by Wall St. Rank hold IX as of Q1 2026.

  • Vident Advisory held 16,747 shares of ORIX worth $502K as of Q1 2026.
  • Vident Advisory bought 2,378 ORIX shares in Q1 2026, an estimated $75.5K.
  • ORIX made up ﹤0.01% of Vident Advisory's portfolio in Q1 2026, its #1257 holding.
  • Vident Advisory first reported a position in ORIX in Q3 2023 and has held it in 8 quarters since.
  • Vident Advisory's ORIX position peaked at $1.76M in Q3 2024.
  • 280 funds tracked by Wall St. Rank held ORIX as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.